NM_000397.4:c.1165G>A
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_000397.4(CYBB):c.1165G>A(p.Gly389Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G389E) has been classified as Uncertain significance.
Frequency
Consequence
NM_000397.4 missense
Scores
Clinical Significance
Conservation
Publications
- granulomatous disease, chronic, X-linkedInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- chronic granulomatous diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked Mendelian susceptibility to mycobacterial diseases due to CYBB deficiencyInheritance: XL, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Granulomatous disease, chronic, X-linked Pathogenic:1
- -
not provided Uncertain:1
Variant summary: The CYBB c.1165G>A (p.Gly389Arg) variant involves the alteration of a conserved nucleotide, resulting in a missense change from a non-polar Gly to a positively charged Arg residue. Gly389 is a highly conserved amino acid across species located in the dehydrogenase domain of the protein. This variant is located in a mutation hotspot since missense changes at this residue have been cited in multiple X-CGD patients, indicating that missense changes at this residue are not tolerated. 5/5 in silico tools predict a damaging outcome for this variant. Functional studies of other missense changes at Gly389 have been shown to abolish NADPH oxidase activity (Beaumel_Biochem Journal_2014). This variant was absent in 86756 control chromosomes, but has been cited in one patient in CYBB base. Because of the limited clinical information and the lack of functional studies on this particular missense variant, the variant was classified as a variant of uncertain significance (VUS)-possibly pathogenic until additional information becomes available. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at